These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 25129312)
1. Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma. Meng FL; Wang W; Jia WD Med Oncol; 2014 Sep; 31(9):177. PubMed ID: 25129312 [TBL] [Abstract][Full Text] [Related]
2. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L; Chu F; Cao Y; Shao J; Wang F Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism. Cao C; Wang C Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720 [TBL] [Abstract][Full Text] [Related]
4. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance. Yang L; Xu Q; Xie H; Gu G; Jiang J Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage. Sun Q; Li J; Jin B; Wang T; Gu J Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500 [TBL] [Abstract][Full Text] [Related]
6. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival. Liu M; Liu J; Wang L; Wu H; Zhou C; Zhu H; Xu N; Xie Y PLoS One; 2014; 9(10):e109347. PubMed ID: 25275448 [TBL] [Abstract][Full Text] [Related]
7. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
8. Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma. Li N; Zhu Q; Yang C; Li F; Zhou Z; Lv Y; Sang J; Han Q; Liu Z Tumour Biol; 2016 May; 37(5):6607-17. PubMed ID: 26643893 [TBL] [Abstract][Full Text] [Related]
9. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma. Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012 [TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China. Jiang L; Cheng Q; Zhang BH; Zhang MZ Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179 [TBL] [Abstract][Full Text] [Related]
11. Expression of miR-187 and miR-509-3p in serum of primary hepatocellular carcinoma patients and its evaluation of prognosis. Dai G; Shen S; Liu Y; Ma X; Fang Y; Weng Y; Li C J BUON; 2021; 26(4):1340-1345. PubMed ID: 34564990 [TBL] [Abstract][Full Text] [Related]
12. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
13. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma. Wang F; Ying H; He B; Pan Y; Sun H; Wang S Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720 [TBL] [Abstract][Full Text] [Related]
14. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II. Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134 [TBL] [Abstract][Full Text] [Related]
15. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Li L; Guo Z; Wang J; Mao Y; Gao Q Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399 [TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection. Lin K; Huang Q; Zeng J; Ding Z; Wang L; Chen Z; Guo P; Zeng Y; Zhou W; Liu J Dig Dis Sci; 2021 Dec; 66(12):4545-4556. PubMed ID: 33723698 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma. Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203 [TBL] [Abstract][Full Text] [Related]
18. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy. Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473 [TBL] [Abstract][Full Text] [Related]
19. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma. Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356 [TBL] [Abstract][Full Text] [Related]
20. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]